NVO vs BIIB: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A S and Biogen Inc in 2026
NVO
Novo Nordisk A S
$45.51
BIIB
Biogen Inc
$196.39
Key Metrics Comparison
| Metric | NVO | BIIB | Winner |
|---|---|---|---|
| Market Cap | $197.39B | $29.08B | NVO |
| P/E Ratio | 10.43 | 21.16 | NVO |
| EPS (TTM) | $4.27 | $9.31 | BIIB |
| Revenue Growth | 0.2% | 0.0% | NVO |
| Gross Margin | 83.2% | 78.7% | NVO |
Analyze NVO
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NVO or BIIB a better investment?
Comparing NVO and BIIB: Novo Nordisk A S has a market cap of $197.39B while Biogen Inc has $29.08B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NVO and BIIB?
NVO (Novo Nordisk A S) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NVO or BIIB?
Based on P/E ratios, NVO trades at a lower multiple (10.4x vs 21.2x).
Which is growing faster: NVO or BIIB?
NVO has higher revenue growth at 0.2% vs 0.0% for BIIB.
Which company is more profitable: NVO or BIIB?
Novo Nordisk A S (NVO) has higher gross margins at 83.2% compared to 78.7% for BIIB.
Which is the larger company: NVO or BIIB?
Novo Nordisk A S (NVO) is larger with a market cap of $197.39B compared to $29.08B for BIIB.
Should I buy NVO or BIIB in 2026?
Both NVO and BIIB have investment merit. NVO trades at $45.51 while BIIB trades at $196.39. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NVO and BIIB stock?
Key differences: Market Cap ($197.39B vs $29.08B), P/E Ratio (10.4x vs 21.2x), Revenue Growth (0.2% vs 0.0%), Gross Margin (83.2% vs 78.7%).